newsfilter
← Latest News
GlobeNewswire·

Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives

BURLINGTON, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (NASDAQ:ABP) ("Abpro" or the "Company"), a biotechnology company advancing next-generation antibody therapies, today announced that it has